H.C. Wainwright revised its price target for Personalis (NASDAQ:PSNL) shares, dropping it to $8.00 from the previous $11.00. Despite this reduction, the firm maintained a Buy rating on the company's ...
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback